344850 Fumonisin B₁, Fusarium moniliforme - CAS 116355-83-0 - Calbiochem

344850
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service
      Ver precios y disponibilidad
      Click To Print This Page

      Descripción

      Replacement Information

      Tabla espec. clave

      Empirical FormulaCAS #
      C₃₄H₅₉NO₁₅ 116355-83-0

      Precios y disponibilidad

      Número de referenciaDisponiblidad Embalaje Cant./Env. Precio Cantidad
      US1344850-1MG
      Comprobando disponibilidad...
      Disponibilidad a confirmarDisponibilidad a confirmar
      En existencia 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          Ampolla de plást. 1 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          OverviewA cell-permeable mycotoxin that inhibits sphingolipid biosynthesis in rat kidney and in liver microsomes by inhibition of sphingosine N-acyltransferase (ceramide synthase; IC50 = 100 nM). Preferentially inhibits sphingomyelin biosynthesis in neuronal cells. Exhibits carcinogenic properties.
          Catalogue Number344850
          Brand Family Calbiochem®
          SynonymsFB₁
          References
          ReferencesWu, W.I., et al. 1995. J. Biol. Chem. 270, 13171.
          Riley, R.T., et al. 1994. J. Nutr. 124, 594.
          Wolf, G. 1994. Nutr. Rev. 52, 246.
          Merrill, A.H. Jr., et al. 1993. Adv. Lipid Res. 26, 215.
          Merrill, Jr., A.H., et al. 1993. J. Biol. Chem. 268, 27299.
          Voss, K.A., et al. 1993. Nat. Toxins 1, 222.
          Wang, E., et al. 1991. J. Biol. Chem. 266, 14486.
          Harrison, L.R., et al. 1990. J. Vet. Diag. Invest. 2, 217.
          Product Information
          CAS number116355-83-0
          ATP CompetitiveN
          FormWhite to beige powder
          Hill FormulaC₃₄H₅₉NO₁₅
          Chemical formulaC₃₄H₅₉NO₁₅
          ReversibleN
          Structure formula ImageStructure formula Image
          Applications
          Biological Information
          Primary Targetceramide synthase
          Primary Target IC<sub>50</sub>100 nM against sphingosine N-acyltransferase (ceramide synthase)
          Purity≥95% by TLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          RTECSTZ8350000
          Safety Information
          R PhraseR: 40

          Limited evidence of a carcinogenic effect.
          S PhraseS: 22-26-36/37/39

          Do not breathe dust.
          In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
          Wear suitable protective clothing, gloves and eye/face protection.
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Carcinogenic / Teratogenic
          Storage +2°C to +8°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Ficha datos de seguridad (MSDS)

          Título

          Ficha técnica de seguridad del material (MSDS) 

          Certificados de análisis

          CargoNúmero de lote
          344850

          Referencias bibliográficas

          Visión general referencias
          Wu, W.I., et al. 1995. J. Biol. Chem. 270, 13171.
          Riley, R.T., et al. 1994. J. Nutr. 124, 594.
          Wolf, G. 1994. Nutr. Rev. 52, 246.
          Merrill, A.H. Jr., et al. 1993. Adv. Lipid Res. 26, 215.
          Merrill, Jr., A.H., et al. 1993. J. Biol. Chem. 268, 27299.
          Voss, K.A., et al. 1993. Nat. Toxins 1, 222.
          Wang, E., et al. 1991. J. Biol. Chem. 266, 14486.
          Harrison, L.R., et al. 1990. J. Vet. Diag. Invest. 2, 217.

          Citas

          Título
        • Rita Fishelevich, et al. (2006) Ceramide-Dependent Regulation of Human Epidermal Keratinocyte CD1d Expression during Terminal Differentiation. Journal of Immunology 176, 2590-2599.
        • Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision30-January-2017 JSW
          SynonymsFB₁
          DescriptionFumonisin B1 is a neurotoxin and a phytotoxin. A cell-permeable mycotoxin that inhibits sphingolipid biosynthesis in rat kidney and in liver microsomes by inhibition of sphingosine N-acyltransferase (ceramide synthase) (IC50 = 100 nM). Cellular effects also appear to be induced by micromolar levels of FB1. Because it inhibits ceramide synthase activity, it elevates cellular levels of sphingoid bases, including sphinganine, resulting in overall inhibition of sphingolipid biosynthesis. Preferentially inhibits sphingomyelin biosynthesis in neuronal cells. Has carcinogenic properties.
          FormWhite to beige powder
          CAS number116355-83-0
          RTECSTZ8350000
          Chemical formulaC₃₄H₅₉NO₁₅
          Structure formulaStructure formula
          Purity≥95% by TLC
          SolubilityMethanol (5 mg/ml)
          Storage +2°C to +8°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
          Toxicity Carcinogenic / Teratogenic
          Merck USA index14, 4289
          ReferencesWu, W.I., et al. 1995. J. Biol. Chem. 270, 13171.
          Riley, R.T., et al. 1994. J. Nutr. 124, 594.
          Wolf, G. 1994. Nutr. Rev. 52, 246.
          Merrill, A.H. Jr., et al. 1993. Adv. Lipid Res. 26, 215.
          Merrill, Jr., A.H., et al. 1993. J. Biol. Chem. 268, 27299.
          Voss, K.A., et al. 1993. Nat. Toxins 1, 222.
          Wang, E., et al. 1991. J. Biol. Chem. 266, 14486.
          Harrison, L.R., et al. 1990. J. Vet. Diag. Invest. 2, 217.
          Citation
        • Rita Fishelevich, et al. (2006) Ceramide-Dependent Regulation of Human Epidermal Keratinocyte CD1d Expression during Terminal Differentiation. Journal of Immunology 176, 2590-2599.